Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 81% Improvement Relative Risk Oxygen therapy 73% c19early.org/d Ünsal et al. Vitamin D for COVID-19 Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 56 patients in Turkey Lower mortality (p=0.23) and lower need for oxygen therapy (p=0.073), not stat. sig. Ünsal et al., J. Endocrinological Investigation, doi:10.1007/s40618-021-01566-9 Favors vitamin D Favors control
Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID-19 infection
Ünsal et al., Journal of Endocrinological Investigation, doi:10.1007/s40618-021-01566-9
Ünsal et al., Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with.., Journal of Endocrinological Investigation, doi:10.1007/s40618-021-01566-9
Apr 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 56 patients in Turkey showing greater need for oxygen therapy and higher mortality with vitamin D deficiency, and significantly lower risk of pneumonia with vitamin D supplementation.
risk of death, 80.6% lower, RR 0.19, p = 0.23, high D levels 0 of 29 (0.0%), low D levels 2 of 27 (7.4%), NNT 14, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), >=20ng/mL.
risk of oxygen therapy, 73.4% lower, RR 0.27, p = 0.07, high D levels 2 of 29 (6.9%), low D levels 7 of 27 (25.9%), NNT 5.3, >=20ng/mL.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ünsal et al., 5 Apr 2021, retrospective, Turkey, peer-reviewed, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Journal of Endocrinological Investigation (2021) 44:2601–2607 https://doi.org/10.1007/s40618-021-01566-9 ORIGINAL ARTICLE Retrospective analysis of vitamin D status on ınflammatory markers and course of the disease in patients with COVID‑19 infection Y. A. Ünsal1 · Ö. Ö. Gül1 O. Ünsal3 · E. Ertürk1 · S. Cander1 · C. Ersoy1 · E. Aydemir1 · C. Ateş1 · Z. Uzun2 · E. Armağan2 · Received: 28 December 2020 / Accepted: 29 March 2021 / Published online: 5 April 2021 © Italian Society of Endocrinology (SIE) 2021 Abstract Purpose The aim of the study was to investigate the association between serum 25-hydroxyvitamin D status within the last 6 months prior to COVID-19 infection and parameters of immune function and clinical outcomes. Methods Fifty-six patients, who were admitted to the emergency clinic and diagnosed with COVID–19 infection, were included in the study. Data on clinical characteristics, inflammatory parameters and vitamin D status were recorded for each patient. All the participants had data on 25-hydroxyvitamin D status within the last 6 months prior to COVID-19 infection. Results The patients were stratified as those with vitamin D status less than 20 ng/mL and higher than 20 ng/mL. A group with vitamin D status less than 20 ng/mL had lower lymphocyte counts and lower haemoglobin levels that was statistically significant (respectively; p = 0.021, p = 0.035). Higher C-reactive protein (CRP) levels were seen in the vitamin D–deficient group (p = 0.013). It was observed that vitamin D status of the patients who required oxygen therapy were lower than those who did not require oxygen therapy, not statistically significant (p = 0.05). Patients who did not use vitamin D supplementation within 6 months prior to COVID-19 infection had more likely to be diagnosed with pneumonia (p = 0.004). Conclusion Cases with lower vitamin D status had increased inflammatory markers and worse clinical outcomes than patients with higher vitamin D status. This study suggests that vitamin D status can be used as a prognostic factor in COVID-19 patients, and vitamin D supplementation can be recommended to improve the clinical outcomes in COVID-19 infection. Keywords Vitamin D · COVID-19 · Immunity · Anti-inflammatory · Pneumonia E. Armağan earmagan9999@yahoo.com * Y. A. Ünsal yaseminunsalay@gmail.com Ö. Ö. Gül drozenoz@gmail.com O. Ünsal oktayunsal@uludag.edu.tr S. Cander drcander@gmail.com E. Ertürk erturkerdinc@gmail.com C. Ersoy ecanan@uludag.edu.tr 1 E. Aydemir ensaraydemir@gmail.com Faculty of Medicine, Department of Endocrinology and Diseases of Metabolism, Bursa Uludag University, Bursa, Turkey 2 C. Ateş drcsknates@gmail.com Faculty of Medicine, Emergency Department, Bursa Uludag University, Bursa, Turkey 3 Faculty of Medicine, Oncology Department, Ankara Gazi University, Ankara, Turkey Z. Uzun drziyauzun61@gmail.com 13 Vol.:(0123456789)
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit